Skip to main content

Stephen Thomas Keir

Professor in Neurosurgery
Neurosurgery, Neuro-Oncology
Box 3624 Med Ctr, Durham, NC 27710
231 Baker House, Durham, NC 27710

Overview


Brain Tumors, Preclinical Testing, Translational Research

Current Appointments & Affiliations


Professor in Neurosurgery · 2021 - Present Neurosurgery, Neuro-Oncology, Neurosurgery
Member of the Duke Cancer Institute · 1992 - Present Duke Cancer Institute, Institutes and Centers

Recent Publications


The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy.

Journal Article Cancer Immunol Res · June 4, 2024 Identification of immunogenic cancer neoantigens as targets for therapy is challenging. Here, we integrate the whole-genome and long-read transcript sequencing of cancers to identify the collection of neo-open reading frame peptides (NOP) expressed in tumo ... Full text Link to item Cite

Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomas.

Journal Article Nat Commun · January 25, 2024 Stimulating the innate immune system has been explored as a therapeutic option for the treatment of gliomas. Inactivating mutations in ATRX, defining molecular alterations in IDH-mutant astrocytomas, have been implicated in dysfunctional immune signaling. ... Full text Link to item Cite

A neural tract-inspired conduit for facile, on-demand biopsy of glioblastoma.

Journal Article Neurooncol Adv · 2024 BACKGROUND: A major hurdle to effectively treating glioblastoma (GBM) patients is the lack of longitudinal information about tumor progression, evolution, and treatment response. METHODS: In this study, we report the use of a neural tract-inspired conduit ... Full text Link to item Cite
View All Publications

Recent Grants


ATRXmutations,innate immune activation and therapeutic vunerabilityin malignant gliomas

ResearchCollaborator · Awarded by National Cancer Institute · 2022 - 2027

PRECLINICAL THERAPEUTIC SCREENING FOR NEW THERAPIES FOR GLIOBLASTOMA MULTIFORME

ResearchInvestigator · Awarded by Jewish Communal Fund · 2022 - 2026

Evaluation of Cannabinoid Therapeutics in Brain Tumor Xenografts

ResearchPrincipal Investigator · Awarded by Diverse Biotech · 2024 - 2025

View All Grants

Education, Training & Certifications


Duke University · 2019 M.M.C.i.
University of North Carolina, Chapel Hill · 2004 DrPH
University of North Carolina, Chapel Hill · 2001 M.P.H.